论生物技术专利保护中的利益平衡原则  

The Principle of Interests Balancing in the Protection of Biotechnology Patents

作　　者：张炳生[1] 陈丹丹[1] 

机构地区：[1]宁波大学法学院

出　　处：《浙江社会科学》2008年第6期48-54,共7页Zhejiang Social Sciences

基　　金：2006年国家哲学社会科学基金课题“现代生物技术引发的知识产权保护法律问题研究”(课题号:06BFX039)的阶段性研究成果

摘　　要：生物技术专利保护中涉及的利益关系非常复杂,但基本利益主体有三对,即专利权人和社会公众、专利权人和人体基因提供者以及发展中国家和发达国家。对于这些主体之间的利益平衡,首先应确定适度与合理的保护范围,正确处理"限制和反限制"的关系并维持动态的利益平衡,在利益平衡原则指导下协调三对基本利益主体之间的利益关系。It involves many complex interests in the protection of biotechnology patents, however, there are three pairs of basic interest subjects, which are patentees and social public, patentees and gene providers, developed countries and developing countries. On the balance of these interests, the first thing is to determine the appropriate and reasonable scope of protection, then handle the relation of 'restrict and anti- restrict' correctly and maintain dynamic balancing of interests, lastly coordinate the interests of the three pairs of basic interest subjects under the principle of interests balancing.

关 键 词：生物技术 专利 利益平衡 

分 类 号：D923.4[政治法律—民商法学]